Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates

BMC Nephrology

Volumn 9, Issue 1, 2008, Pages

  Al Maskari, Fatma ^a   El Sadig, Mohammed ^a   Obineche, Enyioma ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; QUESTIONNAIRE; SEX DIFFERENCE; UNITED ARAB EMIRATES; ALBUMINURIA; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; MIDDLE AGED; RISK FACTOR; URINE;

ADULT; AGED; ALBUMINURIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; UNITED ARAB EMIRATES;

EID: 41149143157     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-9-1     Document Type: Article

References (45)

1. WHO Expert Committee on Diabetes Mellitus. World Health Organization, Second Report, Geneva, WHO Technical Report Series 1980 646 8 12
2. International Diabetes Federation (IDF) Atlas. http://www.eatlas.idf.org/ Complications/
3. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). R Goeree J Manalich P Grootendorst ML Beecroft DN Churchill, Clin Invest Med 1995 18 6 455 64 8714789
4. 2001 Annual Report. Canadian Organ Replacement (CORR), Ottawa, ON, Canada: Canadian Institute for Health Information 2001
5. Update in Diabetic Nephropathy. EN Obineche Abu Adem, Int J Diabetes & Metabolism 2005 13 1 9
6. Measurement of quality of life in end-stage renal disease: the time trade-off approach. DN Churchill GW Torrance DW Taylor CC Barnes D Ludwin A Shimizu EK Smith, Clin Invest Med 1987 10 1 14 20 3545580
7. Preventing dialysis & transplantation. RL Nicholos Diabetic Kidney Disease, Clinical Diabetes 2003 21 55 62 10.2337/diaclin.21.2.55
8. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study. G Bruno F Merletti A Biggeri G Bargero S Ferrero G Pagano P Cavallo Perin Casale Monferrato Study, Diabetes Care 2003 26 7 2150 5 10.2337/diacare.26.7.2150 12832328
9. Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. CE Mogensen GC Viberti E Peheim D Kutter C Hasslacher W Hofmann R Renner M Bojestig PL Poulsen G Scott J Thoma J Kuefer B Nilsson B Gambke P Mueller J Steinbiss KD Willamowski, Diabetes Care 1997 20 11 1642 6 10.2337/diacare.20.11.1642 9353600
10. Nephropathy in diabetes. American Diabetes Association, Diabetes Care 2004 27 suppl 1 S79 S83 14693934
11. Assessment of a new dipstick test in screening for microalbuminuria in patients with hypertension. LM Gerber K Johnston MH Alderman, Am J Hypertens 1998 11 11 Pt 1 1321 7 10.1016/S0895-7061(98)00136-8 9832175
12. Evaluation of tests for microalbuminuria screening in patients with diabetes. J Incerti T Zelmanovitz JL Camargo JL Gross MJ de Azevedo, Nephrol Dial Transplant 2005 20 11 2402 7 Epub 2005 Aug 16 10.1093/ndt/gfi074 16105865
13. Micral-Test: a qualitative dipstick test for micro-albuminuria. PF Spooren JF Lekkerkerker I Vermes, Diabetes Res Clin Pract 1992 18 83 7 10.1016/0168-8227(92)90003-A 1478156
14. Definitions, diagnosis and classification of diabetes mellitus and its complications. World Health Organisation, Report of a WHO consultation. WHO/NCD/NCS/99.2. Geneva; WHO
15. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. WHO expert consultation, The Lancet 2004 363 157 163 10.1016/S0140-6736(03)15268-3
16. Interpretation of Diagnostic Tests. Jacques Wallach, 8 2006
17. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. JW Meijer AJ Smit EV Sonderen JW Groothoff WH Eisma TP Links, Diabet Med 2002 19 11 962 5 10.1046/j.1464-5491. 2002.00819.x 12421436
18. Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. JW Meijer E van Sonderen EE Blaauwwiekel AJ Smit JW Groothoff WH Eisma TP Links, Diabetes Care 2000 23 6 750 3 10.2337/diacare.23.6.750 10840990
19. The prevalence of microalbuminuria in diabetes: a study from north India. DK Gupta LK Verma PK Khosla SC Dash, Diabetes Res Clin Pract 1991 12 2 125 8 10.1016/0168-8227(91)90089-V 1879303
20. Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. J Allawi PV Rao R Gilbert G Scott RJ Jarrett H Keen GC Viberti HM Mather, Br Med J (Clin Res Ed) 296 6620 462 4 1988 Feb 13 3126860
21. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. AC Burden PG McNally J Feehally J Walls, Diabet Med 1992 9 7 641 5 1511571
22. Significance of proteinuria in type 2 diabetic patients treated at a primary health care center in Abha City, Saudi Arabia. MA Al-Homrami I Abdelmoneim, West Afr J Med 2004 23 3 211 4 15587831
23. Prevalence of microalbuminuria in Saudi Arabians with non-insulin-dependent diabetes mellitus: a clinic-based study. AA ALZaid S Sobki V DeSilva, Diabetes Res Clin Pract 26 2 115 20 1994 Dec 16 10.1016/0168- 8227(94)90148-1 7705192
24. Prevalence and predictors of microalbuminuria in patients with type 2 diabetes mellitus: a cross-sectional observational study in Oman. A Al-Futaisi I Al-Zakwani A Almahrezi R Al-Hajri L Al-Hashmi A Al-Muniri M Farooqui, Diabetes Res Clin Pract 2006 72 2 212 5 Epub 2005 Nov 8 10.1016/j.diabres.2005.10.001 16288817
25. Nephropathy in patients with type 2 diabetes mellitus. E Ritz SR Orth, N Engl J Med 341 15 1127 33 1999 Oct 7 10.1056/NEJM199910073411506 10511612
26. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. MA Gall P Hougaard K Borch-Johnsen HH Parving, BMJ 314 7083 783 8 1997 Mar 15 9080995
27. Diabetic nephropathy. American Diabetes Association, Diabetes Care 2003 26 S94 S98 10.2337/diacare.26.7.2194 12502629
28. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. CE Mogensen, N Engl J Med 310 6 356 60 1984 Feb 9 6690964
29. The association of microalbuminuria and mortality in non-insulin- dependent diabetes mellitus. A systematic overview of the literature. SF Dineen HC Gerstein, Arch Intern Med 157 13 1413 8 1997 Jul 14 10.1001/archinte.157.13. 1413 9224218
30. Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. JF Mann YiQl HC Gerstein, Kidney Int Suppl 2004 92 S59 62 10.1111/j.1523-1755.2004.09215.x 15485420
31. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. HC Gerstein JF Mann Q Yi B Zinman SF Dinneen B Hoogwerf JP Halle J Young A Rashkow C Joyce S Nawaz S Yusuf HOPE Study Investigators, JAMA 286 4 421 6 2001 Jul 25 10.1001/jama.286.4.421 11466120
32. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. JC Verhave HL Hillege JG Burgerhof G Navis D de Zeeuw PE de Jong PREVEND Study Group, J Am Soc Nephrol 2003 14 5 1330 5 10.1097/01.ASN.0000060573.77611.73 12707402
33. Diabetic nephropathy and cardiovascular diseases. S Czekalski, Rocz Akad Med Bialymst 2005 50 122 5 16358950
34. Microalbuminuria: is it a valid predictor of cardiovascular risk? R Tagle M Acevedo DG Vidit, Cleve Clin J Med 2003 70 3 255 61 12678217
35. Retinopathy and microalbuminuria in type II diabetic patients. MR Manaviat M Afkhami MR Shoja, BMC Opthalmology 4 9 2004 Jul 1 10.1186/1471-2415-4-9
36. Prevalence of Microalbuminuria in type 2 diabetic patients In Karachi: Pakistan: a multi-center study. MY Ahmedani MZ Hydrie A Iqbal A Gul WB Mirza A Basit, J Pak Med Assoc 2005 55 9 382 6 16302472
37. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus? JL Herrera-Pombo M Aguilar-Diosdado F Hawkins MM Campos A Moreno A Garcia-Hernandez E Castro LG Garcia-Doncel A Serraclara C Sanchez-Malo F Escobar-Jimenez, Nephron Clin Pract 2005 101 3 c116 21 Epub 2005 Jul 5 10.1159/000086681 16015000
38. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. HH Parving JB Lewis M Ravid G Remuzzi LG Hunsicker Demand investigators, Kidney Int 2006 69 11 2057 63 10.1038/sj.ki.5000377 16612330
39. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. AY Wu NC Kong FA de Leon CY Pan TY Tai VT Yeung SJ Yoo A Rouillon MR Weir, Diabetologia 2005 48 1 17 26 Epub 2004 Dec 23 10.1007/s00125-004-1599-9 15616801
40. Obesity and target organ damage: the kidney. PE de Jong JC Verhave SJ Pinto-Sietsma HL Hillege PREVEND study group, Int J Obes Relat Metab Disord 2002 26 Suppl 4 S21 4 10.1038/sj.ijo.0802213 12457295
41. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. AD Liese HW Hense A Döring J Stieber U Keil, J Hum Hypertens 2001 15 11 799 804 10.1038/sj.jhh.1001266 11687925
42. Body fat distribution and total body fat as risk factors for microalbuminuria in the obese. L Mulyadi C Stevens S Munro J Lingard M Bermingham, Ann Nutr Metab 2001 45 2 67 71 10.1159/000046708 11359031
43. Microalbuminuria precedes the development of NIDDM. L Mykkanen SM Haffner J Kuusisto K Pyorala M Laakso, Diabetes 1994 43 4 552 7 10.2337/diabetes.43.4. 552 8138060
44. Microalbuminuria in NIDDM patients in south India. M Viswanathan C Snehalatha PK Bhattacharyya V Mohan A Ramachandran, Indian J Med Res 1991 94 125 9 1879886
45. Treatment of microalbuminuria in patients with type 2 diabetes mellitus. G Jerums RJ Maclasaac, Treat Endocrinol 2002 1 3 163 73 10.2165/00024677- 200201030-00004 15799209